EFM
E Fund Management Portfolio holdings
AUM
$2.1B
This Quarter Return
+13.49%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.37B
AUM Growth
+$1.37B
(+14%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
122
Reduced
183
Closed
27
Top Buys
| 1 |
Microsoft
MSFT
|
$22.3M |
| 2 |
Pinduoduo
PDD
|
$13.5M |
| 3 |
NIO
NIO
|
$13.1M |
| 4 |
Marvell Technology
MRVL
|
$11.4M |
| 5 |
TSMC
TSM
|
$10.4M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$24.2M |
| 2 |
Legend Biotech
LEGN
|
$19.1M |
| 3 |
Trip.com Group
TCOM
|
$15.6M |
| 4 |
Zai Lab
ZLAB
|
$7.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.55M |
Sector Composition
| 1 | Consumer Discretionary | 36.1% |
| 2 | Technology | 29.22% |
| 3 | Communication Services | 14% |
| 4 | Healthcare | 8.72% |
| 5 | Real Estate | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
SPDR Gold Trust
GLD
$111B
| $2.6M | 0.19% |
14,210
+2,905
| +26% | +$532K |
|
52
Intuit
INTU
$187B
| $2.47M | 0.18% |
5,532
+45
| +0.8% | +$20.1K |
|
53
Costco
COST
$421B
| $2.38M | 0.17% |
4,779
-278
| -5% | -$138K |
|
54
Estee Lauder
EL
$33.1B
| $2.22M | 0.16% |
8,993
-14
| -0.2% | -$3.45K |
|
55
Salesforce
CRM
$245B
| $2.16M | 0.16% |
10,792
+785
| +8% | +$157K |
|
56
Applied Materials
AMAT
$124B
| $2.04M | 0.15% |
16,626
-164
| -1% | -$20.1K |
|
57
Analog Devices
ADI
$120B
| $1.97M | 0.14% |
9,977
-13
| -0.1% | -$2.56K |
|
58
Nike
NKE
$110B
| $1.96M | 0.14% |
15,943
-4,130
| -21% | -$506K |
|
59
Accenture
ACN
$158B
| $1.94M | 0.14% |
6,796
+493
| +8% | +$141K |
|
60
Amgen
AMGN
$153B
| $1.9M | 0.14% |
7,868
-131
| -2% | -$31.7K |
|
61
T-Mobile US
TMUS
$284B
| $1.73M | 0.13% |
11,964
-1,013
| -8% | -$147K |
|
62
Comcast
CMCSA
$125B
| $1.72M | 0.13% |
45,301
-4,030
| -8% | -$153K |
|
63
Netflix
NFLX
$521B
| $1.66M | 0.12% |
4,797
-287
| -6% | -$99.1K |
|
64
Marriott International Class A Common Stock
MAR
$72B
| $1.65M | 0.12% |
9,963
+1,726
| +21% | +$287K |
|
65
Gilead Sciences
GILD
$140B
| $1.62M | 0.12% |
19,501
-846
| -4% | -$70.2K |
|
66
MINISO
MNSO
$7.59B
| $1.58M | 0.12% |
+89,060
| New | +$1.58M |
|
67
Oracle
ORCL
$628B
| $1.54M | 0.11% |
16,585
+1,207
| +8% | +$112K |
|
68
Regeneron Pharmaceuticals
REGN
$59.8B
| $1.48M | 0.11% |
1,805
-128
| -7% | -$105K |
|
69
Lam Research
LRCX
$124B
| $1.41M | 0.1% |
2,659
-3
| -0.1% | -$1.59K |
|
70
Vertex Pharmaceuticals
VRTX
$102B
| $1.4M | 0.1% |
4,450
-180
| -4% | -$56.7K |
|
71
Honeywell
HON
$136B
| $1.38M | 0.1% |
7,196
-487
| -6% | -$93.1K |
|
72
Starbucks
SBUX
$99.2B
| $1.29M | 0.09% |
12,377
-733
| -6% | -$76.3K |
|
73
IBM
IBM
$227B
| $1.28M | 0.09% |
9,758
+724
| +8% | +$94.9K |
|
74
Synopsys
SNPS
$110B
| $1.16M | 0.08% |
3,002
+15
| +0.5% | +$5.8K |
|
75
Moderna
MRNA
$9.36B
| $1.16M | 0.08% |
7,546
+268
| +4% | +$41.2K |
|